Mylan Laboratories Limited Trademarks and Patents

Mygestotec, Agila, Stridabine, Trezert, Efamat 200, Pro-5, Mylan Matrix, Viametol, Neurobexol, Effmat, Ricovir, Prefmat, Abamat Ped, Komefan, Tesaqin, Efamat, Kavideza, Viateltis, Lazena 150, Trezav Ped, Olmydelp, Myhep All, Hep Best Built To Deliver (device), Mydekla 60, Avonza, Rinavo, Ricovir Em, Stavmat 30, Viactrix, Tafigado, Terzala Ped, Dilastav, Lopimat, Stavmat, Alltera, Teflamat, Alltera 125, Vitacillin, Zovilam - Ef, Lnsmat, Lamimat 300, Xafariv, Vancoray, Seema, Nudria, Mygesty, Midisvir, Durart – R 350, Zidomat, Dilastav 30, Demtibi, Ertivan, Erestz, Myltega – Dt, Lenris, Nibcovi, Mydesvir, Famy-pop, Nisanodid, Trabigil, Lazena 300, Mydekla, Mydekla 30, Rabsulan, Albavir, Avantaz, Anzavir, Lnzmat, Kodravir - Cp, Amcovir - P, Duvima, Q-listin, Mydmpa, Ricovanza, Otyculf, Teemat, Terzala, Alzmat, Deratid, Cobarnib, Loshertz, Thyleva, Efamat 100, Leukacin, Amlewdo, Omztris, Atroiza, Mydesmir, Riconev, Ricovir - Ln, Zoberium, Taficita, Anzavir-r, Dilastav 40, Albavir Ped, Myltega, Treslam 40, Durart – R 450, Hepbest, Matrix, Dimple, Desrem, Viafosu-sb, Anmafost, Hiocin-q, Pardiwon, Tygaray, Xagulant, Casporay, Molnatris, Udietris, Olmydelp +, Foraday - Cp, Myvitacillin, Viani, Xiflotiba, Clopytris, Viamitus, Sitazuca, Vogubee, Mirtageo, Cloptyge, Paratevia, Cefxiatim, Paluacta, Emfanef, Mydesrem, Myltega – Dt, Agidap, Durart – R 350, Durart – R 450, Kocitaf, Acriptega, Advanarte, Nematris, Xymarta, Avridela, Emardeba, Alcibicla, Calceutical